首页> 外文期刊>BMC Bioinformatics >CloneCNA: detecting subclonal somatic copy number alterations in heterogeneous tumor samples from whole-exome sequencing data
【24h】

CloneCNA: detecting subclonal somatic copy number alterations in heterogeneous tumor samples from whole-exome sequencing data

机译:CloneCNA:从全外显子组测序数据中检测异质肿瘤样品中的亚克隆体细胞拷贝数变化

获取原文
           

摘要

Background Copy number alteration is a main genetic structural variation that plays an important role in tumor initialization and progression. Accurate detection of copy number alterations is necessary for discovering cancer-causing genes. Whole-exome sequencing has become a widely used technology in the last decade for detecting various types of genomic aberrations in cancer genomes. However, there are several major issues encountered in these detection problems, including normal cell contamination, tumor aneuploidy, and intra-tumor heterogeneity. Especially, deciphering the intra-tumor heterogeneity is imperative for identifying clonal and subclonal copy number alterations. Results We introduce CloneCNA, a novel bioinformatics tool for efficiently addressing these issues and automatically detecting clonal and subclonal somatic copy number alterations from heterogeneous tumor samples. CloneCNA fully explores the log ratio of read counts between paired tumor-normal samples and tumor B allele frequency of germline heterozygous SNP positions, further employs efficient statistical models to quantitatively represent copy number status of tumor sample containing multiple clones. We examine CloneCNA on simulated heterogeneous and real tumor samples, and the results demonstrate that CloneCNA has higher power to detect copy number alterations than existing methods. Conclusions CloneCNA, a novel algorithm is developed to efficiently and accurately identify somatic copy number alterations from heterogeneous tumor samples. We demonstrate the statistical framework of CloneCNA represents a remarkable advance for tumor whole-exome sequencing data. We expect that CloneCNA will promote cancer-focused studies for investigating the role of clonal evolution and elucidating critical events benefiting tumor tumourigenesis and progression.
机译:背景拷贝数改变是主要的遗传结构变异,其在肿瘤的初始化和进展中起重要作用。准确检测拷贝数变化对于发现致癌基因是必要的。在过去十年中,全外显子测序已成为一种广泛使用的技术,用于检测癌症基因组中的各种类型的基因组畸变。但是,在这些检测问题中遇到了几个主要问题,包括正常细胞污染,肿瘤非整倍性和肿瘤内异质性。特别地,解密肿瘤内异质性对于鉴定克隆和亚克隆拷贝数改变是必不可少的。结果我们引入了CloneCNA,这是一种新颖的生物信息学工具,可有效解决这些问题并自动检测来自异类肿瘤样品的克隆和亚克隆体细胞拷贝数变化。 CloneCNA充分探索配对的肿瘤正常样品与种系杂合SNP位置的肿瘤B等位基因频率之间的读数计数的对数比,进一步采用有效的统计模型来定量表示包含多个克隆的肿瘤样品的拷贝数状态。我们在模拟的异质和真实肿瘤样本上检查了CloneCNA,结果表明,与现有方法相比,CloneCNA具有更高的检测拷贝数变化的能力。结论CloneCNA是一种新型算法,可有效,准确地从异质性肿瘤样本中识别体细胞拷贝数变化。我们证明了CloneCNA的统计框架代表了肿瘤全外显子组测序数据的显着进步。我们希望CloneCNA将促进针对癌症的研究,以研究克隆进化的作用并阐明有益于肿瘤肿瘤发生和发展的关键事件。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号